Watch Demo

Slovakia Antihypertensive Industry Outlook 2022 - 2026

See how Slovakia Antihypertensive performed compared to key markets such as Germany, Italy and Spain.

Key Market Indicators

Sales of Slovak antihypertensive medicines are set to reach $27 million by 2026, according to a new report. The report, which was released on Monday, estimated the market size was $25 million in 2021. This represents an annual growth rate of 1.7%. However, since 2001, demand in Slovakia has decreased by 0.5% year-on-year. In 2021, Slovakia was ranked 13th in the global market, with South Korea overtaking with $24.64 million. Italy, Spain, and Australia ranked second, third, and fourth respectively.

Slovakia Antihypertensive Market Data and Forecasts

How much will Slovakia Antihypertensive Market grow to 2026?

Forecast: Renin-Angiotensin System Medicine Sales in Slovakia
Forecast: Antihypertensive Medicine Sales in Slovakia
Forecast: Renin-Angiotensin System Medicine Sales in Slovakia
Forecast: Antihypertensive Medicine Sales in Slovakia
Forecast: Renin-Angiotensin System Medicine Sales in Slovakia
More in Antihypertensive Industry for 2027

Improve your Knowledge with the latest Indicators and Trends